Neoadjuvant therapy in elderly HER2-positive breast cancer

Clinical trials for Neoadjuvant therapy in elderly HER2-positive breast cancer explained in plain language.

Never miss a new study

Get alerted when new Neoadjuvant therapy in elderly HER2-positive breast cancer trials appear

Sign up with your email to follow new studies for Neoadjuvant therapy in elderly HER2-positive breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Promising combo aims to shrink tumors in elderly breast cancer patients

Disease control Not yet recruiting

This study tests a combination of targeted drugs (trastuzumab and pertuzumab) plus a low-dose chemotherapy (vinorelbine) given before surgery to elderly patients (70+) with HER2-positive breast cancer. The goal is to see if this approach can completely eliminate cancer cells in t…

Matched conditions: NEOADJUVANT THERAPY IN ELDERLY HER2-POSITIVE BREAST CANCER

Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:33 UTC

Neoadjuvant therapy in elderly HER2-positive breast cancer

Get alerted when new Neoadjuvant therapy in elderly HER2-positive breast cancer trials appear

Promising combo aims to shrink tumors in elderly breast cancer patients